Hazel Robson is an accomplished Intellectual Property attorney with a deep understanding of the pharmaceutical and chemical landscapes. Her expertise spans a broad range of pharmaceutical IP, encompassing new chemical entities, polymorphs, formulations, manufacturing processes, and medical devices. With a strong foundation gained from supporting drug discovery, development, and clinical trials at a global pharmaceutical company, Hazel brings a wealth of industry knowledge and strategic acumen to her work. Hazel works collaboratively with her clients and is adept at drafting patent applications and securing protection at the EPO as well as advising on IP licensing and acquisition agreements. By combining a commercial approach with outstanding analytical skills and legal knowledge, Hazel excels at devising and delivering strategic IP plans and patent portfolio and lifecycle management to maximise IP returns.
